ALS Life Sciences Limited
ALS Life Sciences Limited, headquartered in Ireland (IE), is a prominent player in the global life sciences industry. Founded in 1976, the company has established itself as a leader in analytical testing and laboratory services, catering to a diverse range of sectors including pharmaceuticals, food and beverage, and environmental testing. With operational facilities across Europe, ALS Life Sciences offers a comprehensive suite of services, including microbiological testing, chemical analysis, and regulatory compliance support. Their commitment to quality and innovation sets them apart, ensuring clients receive accurate and timely results. Recognised for their expertise, ALS Life Sciences has achieved significant milestones, including numerous accreditations and partnerships that enhance their market position. Their dedication to scientific excellence and customer satisfaction continues to drive their success in the competitive life sciences landscape.
DitchCarbon Score
How does ALS Life Sciences Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Insurance Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ALS Life Sciences Limited's score of 16 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ALS Life Sciences Limited's reported carbon emissions
In 2023, ALS Life Sciences Limited reported significant carbon emissions, totalling approximately 460,000,000 kg CO2e across all scopes. This includes about 11,922,000 kg CO2e from Scope 1 emissions, primarily from mobile combustion, and approximately 54,528,000 kg CO2e from Scope 2 emissions, mainly from purchased electricity. Scope 3 emissions were notably high, accounting for around 460,000,000 kg CO2e, with major contributions from purchased goods and services (about 298,000,000 kg CO2e) and capital goods (approximately 61,000,000 kg CO2e). In comparison, the 2022 emissions data indicated a total of about 92,300,000 kg CO2e for Scope 1, 47,800,000 kg CO2e for Scope 2, and 14,500,000 kg CO2e for Scope 3. This reflects a complex emissions profile, with a notable increase in Scope 3 emissions in 2023. Despite the detailed emissions reporting, ALS Life Sciences Limited has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company operates within a challenging industry context, where addressing carbon emissions is critical for sustainability and compliance with evolving regulatory frameworks.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 92,300,000 | 00,000,000 |
| Scope 2 | 47,800,000 | 00,000,000 |
| Scope 3 | 14,500,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ALS Life Sciences Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
